FibroGen Announces Leadership Transition
Appoints Thane Wettig as Interim Chief Executive Officer Wettig succeeds Enrique Conterno and brings over 30 years of global pharmaceutical leadership SAN FRANCISCO, July 25, 2023 -- FibroGen,...
Source: marketscreener.com